31 results
8-K
EX-99.3
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
Post-Closing Eliem may provide to the public;
failure to meet or exceed the financial and development projections of the investment community
DEFM14A
ELYM
Eliem Therapeutics Inc
4 Jun 24
Proxy related to merger
8:00am
of the investment community;
if Post-Closing Eliem does not achieve the perceived benefits of the Acquisition as rapidly or to the extent anticipated, or at all … and sole investment power with respect to all shares that they beneficially own, subject to applicable community property laws.
Applicable ownership
PREM14A
ELYM
Eliem Therapeutics Inc
17 May 24
Preliminary proxy related to merger
4:36pm
;
failure to meet or exceed the financial and development projections of the investment community;
if Post-Closing Eliem does not achieve the perceived … and sole investment power with respect to all shares that they beneficially own, subject to applicable community property laws.
Applicable ownership
DEFA14A
8ad2zqr2qa 2asuys3fp
11 Apr 24
Additional proxy soliciting materials
8:10am
8-K
EX-2.1
1x0d9p9q av274
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
8-K
EX-99.2
urbqf53imzs1p37gdw
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
DEF 14A
u93h8z
8 Apr 22
Definitive proxy
4:20pm
10-K
v70 llkm9b
7 Mar 22
Annual report
4:03pm
10-Q
8k5ydm6ve1r9 2u7q
13 Sep 21
Quarterly report
4:01pm